We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

87 hedge funds and large institutions have $1.06B invested in Vaxcyte in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 6

70% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 20

12% more funds holding

Funds holding: 78 → 87 (+9)

1.94% more ownership

Funds ownership: 82.77% → 84.71% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

3% less capital invested

Capital invested by funds: $1.1B → $1.06B (-$32.9M)

Holders
87
Holders Change
+9
Holders Change %
+11.54%
% of All Funds
1.34%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
16
Increased
34
Reduced
20
Closed
6
Calls
$502K
Puts
–
Net Calls
+$502K
Net Calls Change
-$132K

Top Buyers

Rank Fund Capital Flow
1
GPP
Great Point Partners
Connecticut
+$9.35M
2
RCM
RA Capital Management
Massachusetts
+$7.99M
3
BlackRock
BlackRock
New York
+$5.87M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$3.56M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$2.67M

Top Sellers

Rank Fund Capital Flow
1
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$6.84M
2
UBS Group
UBS Group
Switzerland
-$1.78M
3
SM
Sabby Management
Florida
-$1.69M
4
SCM
Soleus Capital Management
Connecticut
-$1.42M
5
AAA
Affinity Asset Advisors
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
76
Manchester Capital Management
Vermont
$36K – – –
Ensign Peak Advisors
77
Ensign Peak Advisors
Utah
$34K +$33K +1,420 New
Nisa Investment Advisors
78
Nisa Investment Advisors
Missouri
$29K +$35.6K +1,530 New
Canada Life
79
Canada Life
Manitoba, Canada
$25K – – –
Macquarie Group
80
Macquarie Group
Australia
$22K -$24.7K -1,064 -53%
Daiwa Securities Group
81
Daiwa Securities Group
Japan
$4K – – –
TWA
82
TCI Wealth Advisors
Arizona
$3K – – –
Carson Wealth (CWM LLC)
83
Carson Wealth (CWM LLC)
Nebraska
$1K +$512 +22 New
BBHC
84
Brown Brothers Harriman & Co
New York
$905 – – –
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$511 +$2.35K +101 +0.5%
SM
86
Sabby Management
Florida
– -$1.69M -66,483 Closed
AAA
87
Affinity Asset Advisors
New York
– -$1.27M -50,000 Closed
ECM
88
ExodusPoint Capital Management
New York
– -$363K -14,300 Closed
Principal Financial Group
89
Principal Financial Group
Iowa
– -$257K -10,121 Closed
PCM
90
Penserra Capital Management
California
– -$30K -1,195 Closed
PA
91
Parallel Advisors
California
– -$1K -28 Closed
S
92
SignatureFD
Georgia
– +$209 +9 New
C
93
Covestor
United Kingdom
– +$395 +17 New
1 2 3
4

PCVX Hedge Fund Activity: Q4 2021 in Review

87 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q4 2021, worth a combined $1.06B — down 3% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new PCVX positions and 6 closed out — a net gain of 10 holders — while 34 added to existing stakes and 20 trimmed.

The largest buyer was Great Point Partners, adding an estimated $9.35M. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $6.84M.

  • 87 institutional investors held Vaxcyte (PCVX) as of Q4 2021, up from 78 in Q3 2021.
  • Funds reported $1.06B of Vaxcyte stock for Q4 2021, down 3% quarter-over-quarter.
  • 16 funds opened new Vaxcyte positions in Q4 2021 and 6 closed out, a net change of +10 holders.
  • The largest Vaxcyte buyer in Q4 2021 was Great Point Partners, an estimated $9.35M added.
  • The largest Vaxcyte seller in Q4 2021 was Pivotal bioVenture Partners Investment Advisor, an estimated $6.84M sold.

Based on aggregated 13F filings for Q4 2021.